Trump doled out billions to drug makers and hospitals with few strings attached

WASHINGTON — The Trump administration has pumped billions of dollars into the healthcare industry during the COVID-19 crisis, padding bottom lines at some of the country’s most profitable businesses even as millions of Americans have been left struggling with mounting medical bills. And although taxpayer money has poured into drug makers, hospital systems and medical distributors, administration officials have put few requirements on the businesses that took public assistance. Pharmaceutical companies could charge more for vaccines and treatments developed with public money. Medical distributors that received government assistance to air-lift supplies from China this spring were...